Download presentation
Presentation is loading. Please wait.
Published byJoel Ellis Modified over 9 years ago
1
Implementing pre-transplant performance review by the Membership and Professional Standards Committee Membership & Professional Standards Committee Fall 2014
2
Performance review includes only post-transplant performance and functional inactivity Unbalanced review of transplant programs Previous high profile incidences of waiting list mismanagement The Problem
3
Need tool to identify and review programs that need pre-transplant performance improvement Areas to monitor: Acceptance of deceased donor organ offers Transplantation of patients on the waiting list Mitigation of waiting list mortality Goal of the Proposal
4
Use composite pre-transplant metric (CPM) that includes: Waiting list mortality rates (liver programs) Geography-adjusted transplant rates Organ offer acceptance rates Safety net metric based on waiting list mortality Identify outlier programs that may need pre- transplant performance review Balanced program performance review How the Proposal will Achieve its Goal
5
July 2009 - CPM concept initially presented to MPSC CPM work group December 2011 - pilot and survey Presentations/Discussions American Transplant Congress Transplant Management Forum PSR Consensus Conference Long Term Effort
6
Incorporate acceptance rates but temper impact No single metric fully represents pre-transplant performance Mitigates effect of geography Identifies programs needing improvement that would not be identified by single metric Summary statistic to prioritize MPSC resources Composite Metric?
7
Using acceptance rates alone Using transplant rates alone Using independent acceptance, transplant, and mortality rate thresholds Life Years from Listing (LYFL) CUSUM –potential complementary tool to CPM in the future Alternative Approaches Considered
8
Weighting the CPM sub-components Accounting for varying sample sizes among programs Adjusting for geography (supply-to-demand) Including both living and deceased donor transplants Including both active and inactive patients Choosing a threshold for identifying programs Use of a “safety net” Other Key Decision Points
9
Review transplant program based on pre-transplant performance if the program meets either of the following criteria over a 1-year period: CPM >1.5 waiting list mortality rate O/E ratio > 2.0 and one-sided p- value < 0.05 At first, only liver and kidney programs In an example analysis, 14 programs were newly identified for review Thresholds for Identification
10
Supporting Evidence Based on 2011 data, 6 (5%) liver programs had CPM above 1.5.
11
Supporting Evidence (cont’d) Based on 2011 data, 16 (7%) kidney programs had CPM above 1.5.
12
Supporting Evidence (cont’d) “Safety net”: 3 kidney and 2 liver programs had statistically significant waitlist mortality O/E > 2.0.
13
Supporting Evidence (cont’d) The two high profile cases of waitlist mismanagement from the mid-2000’s had outlying CPM values. Program 1 Program 2
14
No additional data submission for CPM analysis Respond to inquiry from MPSC if identified for review. Will request information on: waiting list management process any unique clinical aspects (i.e., potential mitigating factors) that may influence ability to meet the thresholds What Members will Need to Do
15
Age Blood type History of cancer BUN Death circum. Insulin administered Antihypertensive admin. Liver biopsy & % macro fat PHS increased risk Proteinuria SGP/ALT Location & distance Liver Acceptance Rate Model Lab MELD Match MELD & status Serum sodium Albumin Dialysis past week HCC exception Previous malignancy Height Time on waitlist other factors… Candidate factors Donor factors SGP/ALT HTLV EBV
16
Jonathan Chen, M.D. Committee Chair jonathan.chen@seattlechildrens.org jonathan.chen@seattlechildrens.org Regional representative name (RA will complete) Region X Representative email address Sharon Shepherd Committee Liaison sharon.shepherd@unos.org sharon.shepherd@unos.org Questions?
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.